A Deep Dive into Muscle Wasting Disorders Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034

What Are the Market Size and Growth Forecast for the Muscle Wasting Disorders Market?
The muscle-wasting disorders market has grown rapidly in recent years. It is expected to increase from $15.06 billion in 2024 to $17.54 billion in 2025, with a CAGR of 16.5%. The historical growth was driven by the aging population, the rising prevalence of chronic diseases, advancements in research and development, increased awareness of early diagnosis, and emerging therapeutic approaches.

The muscle wasting disorders market is set to grow to $29.67 billion by 2029, with a CAGR of 14.1%. Factors driving this growth include regulatory support, patient advocacy, healthcare infrastructure development, global clinical trials, and personalized medicine. Key trends include the use of telemedicine, technological advances in diagnostics, product innovations, collaborations and partnerships, and advancements in therapeutics, molecular mechanisms research, and biopharmaceutical innovation.

What Is Contributing to the Growth of the Muscle Wasting Disorders Market?
The growing prevalence of sedentary lifestyles is fueling the muscle wasting disorders market. A sedentary lifestyle involves limited physical activity, leading to weakened muscle function, reduced strength, and an increased risk of muscle-wasting disorders. For instance, in 2022, the World Health Organization, a Switzerland-based intergovernmental organization, reported that over 80% of adolescents and 27% of adults failed to meet recommended physical activity levels. As a result, the prevalence of sedentary habits is driving the muscle wasting disorders market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13706&type=smp

Which Key Market Leaders Are Driving Muscle Wasting Disorders Industry Growth?
Major companies operating in the muscle wasting disorders market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.), Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Axogen, Inc., FibroGen Inc., Cytokinetics Incorporated, Italfarmaco S.p.A., Scholar Rock, Bellerophon Therapeutics, Akashi Therapeutics, aTyr Pharma, Metabolic Solutions Development Company, Synaptogenix, MyoKardia, Inc., MyoTherix Inc.

What Are the Emerging Trends in the Muscle Wasting Disorders Industry?
Leading companies in the muscle wasting disorders market are focusing on developing cutting-edge treatments, including novel gene therapy, to enhance care for patients with muscle wasting conditions. Novel gene therapy involves modifying gene expression or altering cellular properties to achieve therapeutic effects. For example, in June 2023, Sarepta Therapeutics, a biotechnology company based in the US, launched Elevidys, the first gene therapy approved by the U.S. Food and Drug Administration (FDA) for treating Duchenne muscular dystrophy (DMD) in pediatric patients aged 4 to 5 years. Elevidys is a recombinant gene therapy that introduces a gene encoding a shortened dystrophin protein to support muscle function. The treatment is administered via a single intravenous infusion.

What Are the Main Segments in the Muscle Wasting Disorders Market?
The muscle wasting disorders market covered in this report is segmented -

1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types
2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types
3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users

Subsegments:
1) By Medications: Anabolic Steroids, Hormonal Treatments, Anti-Inflammatory Drugs, Immunomodulatory Agents
2) By Physical Therapy: Resistance Training, Stretching Exercises, Aerobic Conditioning, Rehabilitation Programs
3) By Nutritional Therapy: Protein Supplements, Nutritional Counseling, Dietary Modifications, Micronutrient Supplements
4) By Surgery: Surgical Interventions For Muscle Repair, Orthopedic Surgeries, Procedures For Underlying Conditions
5) By Gene Therapy: Gene Replacement Therapy, CRISPR-Based Approaches, RNA Interference Techniques
6) By Other Treatment Types: Complementary Therapies, Psychological Support, Assistive Devices

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report

Which Geographic Area Leads the Muscle Wasting Disorders Market?
North America was the largest region in the muscle wasting disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Muscle Wasting Disorders Global Market Report?

- Market Size Analysis: Analyze the Muscle Wasting Disorders Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Muscle Wasting Disorders Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Muscle Wasting Disorders Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Muscle Wasting Disorders Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13706

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.